OTCPK:BIAD

Stock Analysis Report

Executive Summary

Bio-AMD, Inc., through its subsidiary, Bio AMD Holdings Limited, focuses on developing hand held electronic medical diagnostic devices.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Share Price & News

How has Bio-AMD's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-8.4%

BIAD

1.7%

US Medical Equipment

2.3%

US Market


1 Year Return

-78.2%

BIAD

10.1%

US Medical Equipment

5.6%

US Market


Shareholder returns

BIADIndustryMarket
7 Day-8.4%1.7%2.3%
30 Day110.7%-1.7%-1.0%
90 Day-46.9%-1.7%-0.7%
1 Year-78.2%-78.2%11.0%10.1%7.9%5.6%
3 Year-87.7%-87.7%70.4%65.2%45.6%36.3%
5 Year-93.7%-93.7%128.5%103.2%65.8%47.6%

Price Volatility Vs. Market

How volatile is Bio-AMD's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Bio-AMD undervalued compared to its fair value and its price relative to the market?


Share Price vs. Fair Value

Information is not available.

Information is not available.


Price To Earnings Ratio

Information is not available.

Information is not available.


Price to Earnings Growth Ratio

Information is not available.


Price to Book Ratio

Information is not available.


Next Steps

Future Growth

How is Bio-AMD forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.5%

Forecasted Healthcare industry annual growth in earnings


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Information is not available.

Information is not available.

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Information is not available.

Information is not available.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Bio-AMD performed over the past 5 years?

17.0%

Historical Healthcare annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Information is not available.

Information is not available.

Information is not available.


Return on Equity

Information is not available.


Return on Assets

Information is not available.


Return on Capital Employed

Information is not available.


Next Steps

Financial Health

How is Bio-AMD's financial position?


Financial Position Analysis

Information is not available.

Information is not available.


Debt to Equity History and Analysis

Information is not available.

Information is not available.


Balance Sheet

Information is not available.

Information is not available.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Information is not available.

Information is not available.


Next Steps

Dividend

What is Bio-AMD's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Information is not available.

Information is not available.

Stable Dividend: Insufficient data to determine if BIAD's dividends per share have been stable in the past.

Information is not available.


Current Payout to Shareholders

Information is not available.


Future Payout to Shareholders

Information is not available.


Next Steps

Management

What is the CEO of Bio-AMD's salary, the management and board of directors tenure and is there insider trading?

US$145k

CEO Compensation


CEO

Tom Barr (58yo)

10.2yrs

Tenure

US$145,176

Compensation

Mr. Thomas Barr, also known as Tom has been the Chief Executive Officer of Bio-AMD, Inc since December 2008. Mr. Barr served as Vice President of Stock Alternative Fuel Operations at Flex Fuels Energy Inc. ...


CEO Compensation Analysis

Information is not available.

Information is not available.


Insider Trading

Information is not available.


Ownership Breakdown


Management Team

  • Tom Barr (58yo)

    CEO & Director

    • Tenure: 10.2yrs
    • Compensation: US$145.18k
  • Helen Wallace

    Group Financial Controller

    • Tenure: 0yrs
  • David Miller (58yo)

    President

    • Tenure: 10.2yrs
    • Compensation: US$94.28k

Board Members

  • Tom Barr (58yo)

    CEO & Director

    • Tenure: 10.2yrs
    • Compensation: US$145.18k
  • David Miller (58yo)

    President

    • Tenure: 10.2yrs
    • Compensation: US$94.28k

Company Information

Bio-AMD, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bio-AMD, Inc.
  • Ticker: BIAD
  • Exchange: OTCPK
  • Founded: 2006
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$290.568k
  • Shares outstanding: 45.98m
  • Website: https://www.bioamd.com

Location

  • Bio-AMD, Inc.
  • Sci-Tech Daresbury
  • Keckwick Lane
  • Daresbury
  • Cheshire
  • WA4 4FS
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BIADOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJun 2007

Biography

Bio-AMD, Inc., through its subsidiary, Bio AMD Holdings Limited, focuses on developing hand held electronic medical diagnostic devices. It offers point of care (POC) medical diagnostic products, including  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/02/07 00:13
End of Day Share Price2019/02/01 00:00
Earnings2016/09/30
Annual Earnings2015/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.